Crizotinib is used to treat non-small cell lung cancer. The drug inhibits anaplastic lymphoma kinase by competing for the ATP-binding site of the enzyme. Crizotinib is also in clinical trials for the treatment of disseminated anaplastic large-cell lymphoma and neuroblastoma. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Science Source / Greg Williams |
Bildgröße: | 6600 px × 3900 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |